APPROACH UNDER REVIEW: `rag`

SCENARIO ID: scenario_10
APP DESCRIPTION: CareAir is an AI radiology assistant for chest X-rays. It runs on the radiologist's workstation, highlights potential nodules and pneumothoraces. It's a second-reader, the radiologist always reviews. CE-marked Class IIa, deployed in 30 hospitals across EU.

DEVELOPER PERSONA: Clinical AI veteran, very familiar with regulation and clinical evidence requirements.

EXPECTED HERA DIMENSIONS (gold standard): P1.D2, P3.D5, P4.D1, P4.D2, P5.D1, P5.D3, P5.D4, P6.D1, P6.D5, P7.D3, P7.D5, P7.D6, P7.D7

TRANSCRIPT:
### USER
CareAir is an AI radiology assistant for chest X-rays. It runs on the radiologist's workstation, highlights potential nodules and pneumothoraces. It's a second-reader, the radiologist always reviews. CE-marked Class IIa, deployed in 30 hospitals across EU.

### ASSISTANT
What is the **worst plausible consequence** of a false positive or false negative in CareAir's detection of nodules and pneumothoraces? [mdr_2017_745 · p.32]

### USER
Prospective multi-centre study N=4500; AUROC 0.96 nodules, 0.94 pneumothorax. Radiologist+AI accuracy 4% higher than radiologist alone.

### ASSISTANT
What is the **specific clinical evidence** you have to support that the worst harm is "moderate" (IIa) and not "serious" (IIb)? [mdr_2017_745 · p.32]

### USER
CE Class IIa. EU AI Act high-risk obligations mapped + documented.

### ASSISTANT
What is the **specific technical documentation** you have prepared to demonstrate how the AI system's risk-management system meets the requirements of Art. 9-15 of the EU AI Act? [card_ai_act_high_risk · p.0]

### USER
Vision Transformer trained on ~1M chest X-rays. Calibrated probabilities. Multilingual report generation.

### ASSISTANT
What is the **specific methodology** you used to ensure the calibration of probabilities meets the robustness and accuracy requirements of Art. 15 of the EU AI Act? [card_ai_act_high_risk · p.0]

### USER
The nodule and pneumothorax highlights are model estimates with calibrated probabilities and the multilingual report text is AI-generated as a second-read rather than validated ground truth, but I'll admit we don't put an explicit 'this is an estimate, not a diagnosis' label on every generated report line.

### ASSISTANT
What is the **specific strategy** you have implemented to ensure that the AI-generated multilingual reports do not mislead users into treating the model's estimates as definitive diagnoses, in line with the transparency requirements of [ai_act_transparency]? [card_ai_act_high_risk · p.0]

### USER
Quarterly drift monitoring, automatic comparison to radiologist final read, vigilance reporting to Swissmedic.

### ASSISTANT
What is the **specific structure** of your vigilance reporting to Swissmedic, including how you will document and classify incidents in line with the MDR PMS requirements and the nFADP Art. 21 obligations for automated decision-making? [card_pms_lifecycle · p.0]

### USER
We do quarterly drift monitoring with automatic comparison to the radiologist final read and vigilance reporting to Swissmedic, but I recognize a quarterly cadence can lag a fast event like a hospital swapping in a new scanner model overnight; we don't currently auto-page on real-time distribution shift.

### ASSISTANT
What is the **specific real-time or near-real-time mechanism** you are considering to detect and respond to distribution shift caused by sudden changes in imaging equipment, in alignment with the AI Act's risk-management requirements for high-risk AI systems under [ai_act_risk_management]? [card_ai_act_high_risk · p.0]

### USER
If our AI service is unavailable the radiologist's PACS workstation workflow continues as standard radiology, but I'm not going to claim the failover UI signalling is fully hardened — we haven't documented all the degraded-mode failure paths.

### ASSISTANT
What is the **specific degraded-mode failure path** you are documenting for the AI service unavailability, including how the radiologist's workflow is preserved and how the system communicates the loss of AI assistance in line with the transparency and robustness requirements of [ai_act_risk_management]? [card_ai_act_high_risk · p.0]

### USER
PACS workstation only; not patient-facing.

### ASSISTANT
What is the **specific communication mechanism** you have implemented to ensure radiologists are clearly informed of AI service unavailability on the PACS workstation, in line with the transparency and robustness requirements of [ai_act_risk_management], and how does this align with the MDR's General Safety and Performance Requirements (Annex I) for system usability? [card_mdr_class_iiia · p.0]

### USER
We integrate at the PACS workstation and consume DICOM that the hospital has anonymized before transfer, but we don't currently push structured findings back over FHIR into the hospital EHR — interoperability beyond PACS is something we haven't built out.

### ASSISTANT
What is the **specific plan** you have to ensure structured findings from CareAir are interoperable with hospital EHRs via FHIR, in line with the MDR's General Safety and Performance Requirements (Annex I) and the EU AI Act's interoperability obligations under [ai_act_high_risk]? [card_mdr_class_iiia · p.0]

### USER
We've mapped CareAir as EU AI Act high-risk and documented those obligations alongside the MDR Rule 11 Class IIa classification, and I'm confident that classification is correct given it's a CE-marked AI medical device.

### USER
Thanks for the conversation. Could you produce a brief structured risk report now? Use HERA dimension IDs (e.g. [P1.D2]) and group risks by severity. End the report with a list of dimensions you didn't get to cover.

### ASSISTANT
**HERA Risk & Safety Report for CareAir**  
*AI Radiology Assistant for Chest X-rays (CE Class IIa, EU AI Act High-risk)*  

---

### **High Severity Risks**  
1. **[P2.D3] Transparency & Interpretability**: AI-generated reports lack explicit labeling of estimates vs. diagnoses, risking misinterpretation as definitive findings. Mitigation: Implement clear UI labels per [ai_act_transparency] and [mdr_2017_745 · p.32].  
2. **[P3.D4] Robustness & Resilience**: No real-time detection of distribution shift from new imaging equipment, risking performance degradation. Mitigation: Develop near-real-time monitoring per [ai_act_risk_management] and [card_ai_act_high_risk · p.0].  
3. **[P4.D5] Data Quality & Integrity**: No structured findings pushed to EHR via FHIR, limiting interoperability and clinical integration. Mitigation: Plan FHIR integration per [mdr_2017_745 · p.32] and [ai_act_high_risk].  

---

### **Medium Severity Risks**  
1. **[P1.D1] Data Protection & Privacy**: Use of health data without explicit consent or legal basis (e.g., Art. 9(2)(h)) could breach GDPR. Mitigation: Ensure compliance with [gdpr_art9 · p.0] and [ai_act_data_governance].  
2. **[P5.D6] Clinical Evaluation & Evidence**: Limited evidence for IIa classification (vs. IIb) could risk reclassification. Mitigation: Strengthen clinical evaluation per [mdr_2017_745 · p.32] and [clinical_eval_mdsw].  
3. **[P6.D7] Post-Market Surveillance**: Quarterly drift monitoring may lag fast-changing scenarios. Mitigation: Integrate real-time monitoring per [card_pms_lifecycle · p.0] and [ai_act_risk_management].  

---

### **Low Severity Risks**  
1. **[P7.D8] System Usability & Workflow**: Degraded-mode failure paths not fully documented, risking workflow disruption. Mitigation: Document all failure paths per [mdr_2017_745 · p.32] and [ai_act_risk_management].  

---

### **Dimensions Not Covered**  
- **[P2.D1] Accountability & Governance**: No mention of governance frameworks or AI ethics oversight.  
- **[P4.D2] Data Governance & Security**: Limited detail on data anonymization and secure handling.  
- **[P5.D3] Clinical Validation & Evidence**: No mention of health-economic studies for reimbursement.  
- **[P6.D5] Risk Management & Mitigation**: No explicit risk mitigation plan for AI Act Art. 15.  
- **[P7.D1] Human Oversight & Interaction**: Limited detail on radiologist-AI collaboration protocols.  

---  
Let me know if you'd like a mitigation plan for any of these dimensions.

Now produce the JSON judgement object.